Amgen Inc (AMGN) announced an update on their ongoing clinical study.
Tv Therapeutics Inc., a late-stage biopharmaceutical company, today announced a Phase 2 clinical study protocol developed in collaboration with M42’s Insights Research Organization & Solutions (IROS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback